We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.29B
AUM Growth
+$137M
Cap. Flow
-$177M
Cap. Flow %
-3.36%
Top 10 Hldgs %
25.42%
Holding
143
New
11
Increased
24
Reduced
86
Closed
7

Top Buys

Rank Stock Value
1
AMED
Amedisys
AMED
+$78.7M
2
EYE icon
National Vision
EYE
+$29.2M
3
FIVN icon
FIVE9
FIVN
+$27.9M
4
DHR icon
Danaher
DHR
+$27.8M
5
DSGX icon
Descartes Systems
DSGX
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 32.05%
2 Healthcare 20.84%
3 Industrials 18.54%
4 Consumer Discretionary 10%
5 Consumer Staples 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLB icon
1
Protolabs
PRLB
$1.79B
$162M 3.06%
1,393,888
-54,732
-4% -$5.89M
CSGP icon
2
CoStar Group
CSGP
$11.7B
$147M 2.79%
2,658,070
-128,850
-5% -$6.59M
GLOB icon
3
Globant
GLOB
$1.58B
$142M 2.69%
1,407,417
-47,785
-3% -$4.16M
LOPE icon
4
Grand Canyon Education
LOPE
$3.79B
$140M 2.65%
1,197,493
-50,994
-4% -$6.09M
RBA icon
5
RB Global
RBA
$20.4B
$135M 2.56%
4,076,884
-156,751
-4% -$5.36M
CHE icon
6
Chemed
CHE
$7.07B
$134M 2.54%
372,495
-61,044
-14% -$20.4M
HEI icon
7
HEICO Corp
HEI
$49.8B
$129M 2.44%
965,652
-590,587
-38% -$65.7M
FIVE icon
8
Five Below
FIVE
$12B
$120M 2.27%
1,001,773
-44,138
-4% -$5.81M
TDOC icon
9
Teladoc Health
TDOC
$1.22B
$117M 2.2%
1,754,498
+230,937
+15% +$13.5M
PRO
10
DELISTED
PROS Holdings
PRO
$116M 2.2%
1,841,221
-108,611
-6% -$5.72M
VEEV icon
11
Veeva Systems
VEEV
$33.1B
$116M 2.19%
713,722
-181,693
-20% -$26.5M
VRSK icon
12
Verisk Analytics
VRSK
$25.4B
$115M 2.18%
785,212
-37,799
-5% -$5.33M
NATI
13
DELISTED
National Instruments Corp
NATI
$112M 2.11%
2,662,338
-109,661
-4% -$4.68M
MSFT icon
14
Microsoft
MSFT
$3.45T
$107M 2.02%
796,242
-3,277
-0.4% -$416K
BL icon
15
BlackLine
BL
$1.84B
$102M 1.93%
1,906,518
+481,071
+34% +$23.9M
FAST icon
16
Fastenal
FAST
$54.7B
$99.5M 1.88%
6,106,840
-288,524
-5% -$4.76M
HCSG icon
17
Healthcare Services Group
HCSG
$1.6B
$94.4M 1.79%
3,114,692
-23,766
-0.8% -$785K
ANSS
18
DELISTED
Ansys
ANSS
$93.2M 1.76%
454,839
-25,167
-5% -$4.79M
GNTX icon
19
Gentex
GNTX
$4.97B
$88M 1.67%
3,577,500
-153,860
-4% -$3.49M
TYL icon
20
Tyler Technologies
TYL
$12.7B
$87.9M 1.66%
406,943
+85,579
+27% +$18.6M
PAYC icon
21
Paycom
PAYC
$7.64B
$87.5M 1.66%
385,998
-17,184
-4% -$3.53M
INFO
22
DELISTED
IHS Markit Ltd. Common Shares
INFO
$84.9M 1.61%
1,332,033
-59,090
-4% -$3.39M
TECH icon
23
Bio-Techne
TECH
$11.2B
$83.1M 1.57%
1,594,300
-103,084
-6% -$5.19M
AMED
24
DELISTED
Amedisys
AMED
$80.5M 1.52%
+662,756
New +$78.7M
PEGA icon
25
Pegasystems
PEGA
$5.02B
$75.9M 1.44%
2,131,098
+574,896
+37% +$20.5M

Similar funds

Riverbridge Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Riverbridge Partners held 143 positions worth $5.29B, up 2.7% from $5.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Riverbridge Partners withdrew a net $177M in Q2 2019, closing 7 positions and reducing 86 holdings. Its most notable exit was Ultimate Software Group Inc, an estimated $162M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Riverbridge Partners opened a new position in Amedisys worth $80.5M.

  • Riverbridge Partners's largest Q2 2019 buy was Amedisys: 662,756 shares worth $80.5M.
  • Riverbridge Partners added most to BlackLine in Q2 2019, an estimated $23.9M increase.
  • Riverbridge Partners's biggest Q2 2019 reduction was HEICO Corp, cutting an estimated $65.7M.
  • Riverbridge Partners fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $162M.
  • Riverbridge Partners's ten largest holdings make up 25% of its $5.29B portfolio in Q2 2019.
  • Riverbridge Partners opened 11 new positions and closed 7 in Q2 2019.
  • Riverbridge Partners's portfolio value rose 2.7% quarter-over-quarter to $5.29B.

Based on Riverbridge Partners's 13F filing for Q2 2019, filed 10 Jul 2019.